U.S. FDA Official Kicks Off India Compliance Workshops Stressing Quality
This article was originally published in PharmAsia News
Executive Summary
The deputy director of the U.S. FDA's international office told drug makers at the first of a year's worth of workshops in India that they must be honest in stating what they will do and that they did it.